Scientists Discover Tryptamine Is the Brain's Built-In Sleep Pressure Signal

Sleep is regulated by two systems: the circadian clock and a homeostatic drive that builds the longer we stay awake. For decades, scientists have known that wakefulness generates sleep-promoting substances, but the specific molecular identities of these substances and how they are sensed by the brain have remained largely unknown. This study addresses that fundamental gap.

Researchers from the Chinese Academy of Sciences and collaborating institutions investigated tryptamine (TrpA), a trace amine found in the brain, as a candidate homeostatic sleep signal. Using cerebrospinal fluid measurements in both nocturnal mice and diurnal pigs, they demonstrated that TrpA levels rise in proportion to wakefulness and physical activity, tracking sleep pressure independently of the light-dark cycle.

To study TrpA dynamics in real time, the team engineered a novel ratiometric fluorescent sensor. They found that wake-active monoaminergic neurons in the diencephalon and brainstem synthesize and release TrpA in an activity-dependent manner. Released TrpA then binds to GPR139, a G-protein-coupled receptor expressed in the hypothalamic preoptic area — a brain region critical for initiating sleep — and boosts neuronal excitability there, promoting sleep onset.

Critically, when TrpA-GPR139 signaling was disrupted, mice failed to show normal sleep rebound after sleep deprivation. Conversely, small-molecule GPR139 agonists administered pharmacologically increased both sleep duration and sleep quality, suggesting clear therapeutic potential.

This research identifies a previously unknown sleep homeostasis circuit and nominates GPR139 as a druggable target for sleep disorders such as insomnia. Caveats include reliance on animal models and abstract-only access, so mechanistic details, dosing parameters, and full safety data require review of the complete manuscript. Human translation will require further validation.